Fondation Mérieux

The Fondation Mérieux is an independent family foundation recognized for public utility created by Charles Mérieux. Its mission is to contribute to global health by strengthening local capacities in developing countries to reduce the impact of infectious diseases on vulnerable populations.

History

The FM was created in 1967 by Doctor Charles Mérieux, in homage to his father Marcel Mérieux, pupil of Louis Pasteur and founder of the Institut Mérieux in 1897. It was recognized in French law as "for public utility" in 1976.[1]

The foundation is present in 18 countries such as Mali, Cambodia, Laos and Haiti. and builds its projects with the health authorities and local partners.[2]

In 2012, the FM continued its partnership with the Chinese Academy of Medical Sciences. The partnership, which is renewed by contract every five years, was begun with Phase I in 2007. In this case, the FM was interested in the study of tuberculosis. Inter alia, Phase I of the CAMS-FM partnership funds trained "132 laboratory professionals at national, prefectural et and municipal levels."[3]

In 2015, the CAMS-FM partnership founded the Christophe Mérieux Laboratory (CML) at the Institute of Pathogen Biology in Beijing to focus on the study pneumonia and tuberculosis. Researchers at the CML "benefit from and training modules developed by the Emerging Pathogens Laboratory in Lyon",[4][5] a BSL-4 lab which was also built by the FM in 1999 and since 2005 is now operated by INSERM.[6]

In 2015, the FM participated in the donation by the French government of CIRI's Biosafety Level 4 expertise to the Wuhan Institute of Virology.[7]

In January 2017, a researcher who was financed by the CAMS-FM partnership participated in a study of human rhinovirus and genotype A21.[8]

In July 2020, it was announced that a researcher employed at the CAMS-FM participated in the development of a low-cost COVID-19 screening test, which uses a variant of the CRISPR technology.[9]

Synopsis

The FM plays a role in the fight against infectious diseases by intervening in various areas:

  • Increase access to diagnosis because diagnosis is an essential tool for surveillance and control of diseases.[10]
  • Reinforce research capacities, in particular by training teams on site and by setting up a research program.[11]
  • Exchange and share knowledge, for the dissemination of global medical advances[12]
  • Acting for mother and child, the most vulnerable to infectious diseases[13]

See also
  • Mérieux Family

References
  1. "Histoire". Fondation Mérieux (in French). 17 September 2013. Retrieved 8 August 2019.
  2. "Where we work". Fondation Mérieux (in French). 17 September 2013. Retrieved 8 August 2019.
  3. "fondation-merieux-continues-its-collaboration-with-the-chinese-ministry-of-health-and-the-chinese-academy-of-medical-sciences". 24 April 2012.
  4. "CHINA". Retrieved 1 September 2020.
  5. "CIRI: EMERGING PATHOGENS LABORATORY / RESEARCH THEMES". Retrieved 1 September 2020.
  6. "P4 Jean Mérieux-Inserm Laboratory". Mérieux Foundation. 17 September 2013.
  7. "China Inaugurates the first biocontainment level 4 laboratory in Wuhan". Chinese Academy of Sciences. 3 February 2015.
  8. Ren, Lili; Yang, Donghong; Ren, Xianwen; Li, Mingkun; Mu, Xinlin; Wang, Qi; Cao, Jie; Hu, Ke; Yan, Chunliang; Fan, Hongwei; Li, Xiangxin; Chen, Yusheng; Wang, Ruiqin; An, Fucheng; An, Shuchang; Luo, Ming; Wang, Ying; Xiao, Yan; Xiang, Zichun; Xiao, Yan; Li, Li; Huang, Fang; Jin, Qi; Gao, Zhancheng; Wang, Jianwei (2017). "Genotyping of human rhinovirus in adult patients with acute respiratory infections identified predominant infections of genotype A21". Scientific Reports. 7 (1): 41601. doi:10.1038/srep41601. PMC 5269714. PMID 28128353.
  9. Hou, Tieying; Zeng, Weiqi; Yang, Minling; Chen, Wenjing; Ren, Lili; Ai, Jingwen; Wu, Ji; Liao, Yalong; Gou, Xuejing; Li, Yongjun; Wang, Xiaorui; Su, Hang; Gu, Bing; Wang, Jianwei; Xu, Teng (2020). "Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19". PLOS Pathogens. 16 (8): e1008705. doi:10.1371/journal.ppat.1008705. PMID 32853291. S2CID 221358467.
  10. "Increase access to diagnosis". Fondation Mérieux (in French). 17 September 2013. Retrieved 8 August 2019.
  11. "Reinforce research capacities". Fondation Mérieux (in French). 17 September 2013. Retrieved 8 August 2019.
  12. "Exchange and share knowledge". Fondation Mérieux (in French). 17 September 2013. Retrieved 8 August 2019.
  13. "Acting for Mother and Child". Fondation Mérieux (in French). 17 September 2013. Retrieved 8 August 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.